| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Anthropic prices upsized IPO at $83, above the range; raises $81B in the largest US IPO ever | ||
| Mi | Thyroid cancer diagnostics provider Interpace Biosciences withdraws $20 million Nasdaq uplisting | ||
| Mi | The 8 C's Behind Anthropic's Biggest Risks | ||
| Mi | IPO Weekly Weigh-in: Anthropic IPO 6x oversubscribed? | ||
| Di | Core Specialty Insurance files for an estimated $250 million IPO | ||
| Mo | Eye disease biotech EIR Biopharma withdraws $17 million IPO | ||
| Mo | Countdown to Anthropic: 7 things you need to know ahead of its IPO | ||
| Sa | US IPO Weekly Recap: Two sizable IPOs price, a multibillion-dollar deal joins the pipeline, and Anthropic sets terms | ||
| Sa | Shipping and logistics provider CloudDepots Holdings files for a $17 million IPO | ||
| 13.11. | US IPO Week Ahead: AI giant Anthropic gears up for historic IPO | ||
| 13.11. | SPAC Compute AI Acquisition files for a $75 million IPO, targeting AI | ||
| 13.11. | How the largest US IPOs performed after listing and what it means for Anthropic | ||
| 13.11. | vVardis Holding offers more shares but prices US IPO below the range at $18 | ||
| 13.11. | Inflammatory disease biotech Rezera postpones $200 million IPO | ||
| 13.11. | Swiss biotech Windward Bio Group prices US IPO at $17, the midpoint of the range | ||
| 12.11. | SPAC Harbour Island Acquisition I decreases units offered by 20% ahead of $80 million IPO | ||
| 12.11. | Cavity treatment provider vVardis decreases shares offered by 13% ahead of $188 million US IPO | ||
| 11.11. | Which AI companies could go public after Anthropic? | ||
| 11.11. | IPO Weekly Weigh-in: This new AI stock has a debt problem | ||
| 11.11. | Gold mining carve-out American Barrick Gold files for an estimated $6 billion IPO | ||
| 10.11. | Anthropic sets terms for $61 billion IPO, targeting a $1.2 trillion market cap | ||
| 09.11. | Bitcoin mining services provider Bitari withdraws $30 million IPO | ||
| 09.11. | SPAC ZA Acquisition I files for a $75 million IPO, targeting established businesses with recurring revenue | ||
| 09.11. | RA Capital's SPAC Research Alliance V files for a $62 million IPO, targeting healthcare | ||
| 09.11. | Switzerland-based respiratory biotech Windward Bio Group sets terms for $175 million US IPO |